The drug "Aspirin-Oopsa" is part of the pharmacological group of non-narcotic analgesics. The agent is often prescribed for various pathologies. The active ingredient is acetylsalicylic acid.
Contraindicated drug with hypersensitivity, hemorrhagic diathesis, exfoliating aneurysm of the aorta, heart failure, recurrent and acute gastrointestinal tract pathologies of erosive and ulcerative nature. The "Aspirin-Upps" remedy is not prescribed for severe disorders of the kidneys and liver, acute liver and kidney deficiency, vitamin K deficiency. Contra-indications include pregnancy in the first trimester, lactation, age up to fourteen years.
As side effects when using the "Aspirin-Upps", we should note a decrease in hearing, dyspepsia, tinnitus, bleeding in the gastrointestinal tract. The use of medication can cause leukopenia, anemia, Reye's syndrome, hypersensitivity reactions, including bronchospasm, urticaria. Prolonged use of Aspirin-Oopsa can lead to the development of interstitial nephritis, papillary necrosis, acute renal failure, aseptic meningitis, increased manifestations of congestive heart failure, edema, and an increase in the level of aminotransferases in the blood.
The drug "Upsarin UPSA" ("Uppsarin-Uppsa") (for whatever it is applied) should be appointed doctor. The agent is recommended in the presence of several factors that can provoke coronary heart disease, with unstable angina, repeated transient ischemia of the brain and ischemic stroke in men. The drug "Aspirin-Oopsa" is prescribed for non-atherosclerotic lesions of the coronary arteries, valvular mitral valvular heart. Indications include valve prosthetics, stent placement (to reduce the likelihood of repeated stenoses and the therapy of secondary coronary artery dissection). The medication is prescribed for recurrent thromboembolism of the pulmonary artery, pericarditis, rheumatism, rheumatoid arthritis, progressive systemic sclerosis, infectious allergic myocarditis, migraine, lumbago, acute thrombophlebitis, neuralgia. The indications include pain syndromes of different intensity. The drug is administered orally at 500-1000 mg per day.
In case of an overdose, general malaise, nausea, vomiting, fever are noted. In more severe cases, patients fall into a coma, convulsions, dehydration, and pulmonary edema are non-cardiogenic. The likelihood of developing intoxication of a chronic nature is more pronounced in persons of advanced age.
In case of an overdose, it is necessary to cause the patient to vomit, give laxative and activated charcoal, urine alkalinization. It should be remembered that carrying out intensive fluid infusion to elderly patients can provoke pulmonary edema. With an elevated level of salicylates, hemodialysis is indicated. When pulmonary edema is carried out, ventilation is an oxygen-enriched mixture. To eliminate cerebral edema , osmotic diuresis and hyperventilation are used.